Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Available laboratory tests to guide antimicrobial therapy.

G F Araj1

  • 1Department of Pathology & Laboratory Medicine, American University of Beirut Medical Center, Lebanon. garaj@aub.edu.lb

Le Journal Medical Libanais. the Lebanese Medical Journal
|February 24, 2001
PubMed
Summary

Physicians face challenges with drug-resistant infections, highlighting the need for effective antimicrobial susceptibility tests. This review guides clinicians in selecting appropriate lab tests to manage bacterial infections and monitor treatment response.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic Characterization of MDR <i>Escherichia coli</i> Harboring <i>bla</i><sub>OXA-48</sub> on the IncL/M-type Plasmid Isolated from Blood Stream Infection.

BioMed research international·2018
Same author

Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.

International journal of antimicrobial agents·2012
Same author

Study of KIR genes in Lebanese patients with tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2011
Same author

First detection of oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Morocco.

Annals of tropical medicine and parasitology·2010
Same author

Spread of OXA-48-mediated resistance to carbapenems in Lebanese Klebsiella pneumoniae and Escherichia coli that produce extended spectrum beta-lactamase.

Annals of tropical medicine and parasitology·2010
Same author

Cutaneous non-tuberculous Mycobacterial infections: a clinical and histopathological study of 17 cases from Lebanon.

Journal of the European Academy of Dermatology and Venereology : JEADV·2010

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Increasing prevalence of single and multi-drug resistant organisms complicates infectious disease management.
  • Physicians require reliable laboratory tests to guide antimicrobial therapy and monitor patient response.
  • Conventional and advanced antimicrobial susceptibility testing methods are crucial for effective treatment.

Purpose of the Study:

  • To review and update physicians on available antimicrobial susceptibility tests.
  • To guide the selection of the most relevant laboratory tests for bacterial infections.
  • To enhance the management of infections caused by drug-resistant bacteria.

Main Methods:

  • Review of conventional antimicrobial susceptibility tests (e.g., disk diffusion, MIC determination, E test).

Related Experiment Videos

  • Discussion of special, automated, and molecular testing methods.
  • Analysis of tests for monitoring therapeutic response (e.g., serum bactericidal titers, antimicrobial levels).

    • Main Results:

    • A comprehensive overview of various antimicrobial susceptibility testing methodologies is presented.
    • The article details the utility of different tests in predicting and monitoring treatment efficacy.
    • Guidance is provided for selecting appropriate tests based on bacterial etiologic agents.

    Conclusions:

    • Effective selection of antimicrobial susceptibility tests is vital for successful infectious disease treatment.
    • Understanding available laboratory tests empowers physicians to combat drug-resistant organisms.
    • This review serves as a resource for optimizing antimicrobial therapy selection and monitoring.